tpatten, if you strongly believe that CO2 has no impact to the climate, then I would suggest you to remove the catalytic converter from your car, move your car inside your garage, close the garage door, start the car while you sit in it and let it run for 30 minutes. Give me an update when the experiment is complete.. I'll send you a check to cover for your gas costs.. LMAO
vpg, what is stopping you from moving to China where pollution is alright, excessive CO2 is not a concern, and China gov't spends nothing to improve air, water and food safety. their philosophy is the same as yours and J20, "the climate has changed for millions of years" so human has nothing to do with the excessive CO2 in the air... you need to travel outside of your double-wide trailer park to learn more about the environment.. LMAO
as long as volume is high ( 5Mils), high Institution Ownership (97.5%), high insider ownership (44.5%) and insiders continue to accumulate, then I'm in for the ride.. GL
obamayoumama, "Please name one drug that had 19 prescriptions before it was released!"... FYI, in 2010 Colorado’s #$%$ prescriptions were 190,000 before it was released .. LMAO...
you need to change your meds or turn yourself in to the psycho hosp before you go postal.... LOL
let's focus on killing the messenger instead of facing the reality.. it is a weak stock... stop making a fool of yourself aszhole..
neshua, what happen to your pumpin' at $24 last week.. and today, you're in reverse course now eh ???
guido, that was a good find.. unfortunately they only show AstraZeneca, Lily, Novo Nordisk, Sanofi, but no Mannkind anywhere.. what happen to the MNKD's PR department ? ...wonder why MNKD stock is not moving..
all of the CLDX drugs will have exact the same revenue. ZERO. This company initiates new clinical trial every month, but none of them will completed. So stop dreaming about the FDA approval, or revenue until 2050...
not true, the company advised that DO NOT USE Afrezza as a substitute for long-acting insulin; Afrezza must be used in combination with long-acting insulin in patients with type 1 diabetes
too many pumpers on this board poisoned the water..they keep confusing retail investors with mis-information and/or hiding the truth by speculating stock price w/o facing the real value of the company.. it is what it is, the current stock price is already built-in the future revenues, the market caps of $2.5 Bil w/o revenue is over-priced.. this is the reason why stock price has not changed as the AFREZZA is ready to launch.
when the high % of shorts and low % of IO, on top of the CEO is stepping aside right before the launch, then something BAD is just about to reveal soon...$6.50 used to be a support, and now became a strong resistance zone.. and everytime it getting closer to this zone, it hits the brick wall... higher risk than reward at this $6.50 level.. GL..
Blackrock is a hedge fund company, their publicized positions are completely reversed of their strategy .. if you think their intentions are very well known, then how old is your brain ? GL
why pumpers on this YMB expect CLDX stock to jump 2X when the Rindo get approved , and they even projected 10X by 2016 ??